Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126809612 | 12680961 | 2 | F | 20160905 | 20160824 | 20160919 | EXP | GB-TEVA-686896ISR | TEVA | GOLDIE FC, BROGAN A, BOYLE JG. CIPROFLOXACIN AND STATIN INTERACTION: A CAUTIONARY TALE OF RHABDOMYOLYSIS. BMJ CASE REPORTS. 2016; ARTICLE NUMBER BCR2016216048 | 62.00 | YR | F | Y | 0.00000 | 20160919 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126809612 | 12680961 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | 40 MG NOCTE | Y | 76052 | 40 | MG | ||||||||
| 126809612 | 12680961 | 2 | I | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | U | 74124 | |||||||||||
| 126809612 | 12680961 | 3 | C | Nicorandil | NICORANDIL | 1 | 20 MILLIGRAM DAILY; | 0 | 10 | MG | BID | ||||||||
| 126809612 | 12680961 | 4 | C | ASPIRIN. | ASPIRIN | 1 | 75 MILLIGRAM DAILY; | 0 | 75 | MG | QD | ||||||||
| 126809612 | 12680961 | 5 | C | Bisoprolol | BISOPROLOL | 1 | 5 MILLIGRAM DAILY; | 0 | 5 | MG | QD | ||||||||
| 126809612 | 12680961 | 6 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | AS NEEDED | 0 | 400 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126809612 | 12680961 | 2 | Urinary tract infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126809612 | 12680961 | OT |
| 126809612 | 12680961 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126809612 | 12680961 | Blood creatine phosphokinase increased | |
| 126809612 | 12680961 | Drug interaction | |
| 126809612 | 12680961 | Hepatic function abnormal | |
| 126809612 | 12680961 | Muscular weakness | |
| 126809612 | 12680961 | Rhabdomyolysis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |